Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the ...

PEACE BY PEACEAs the year comes to a close, I find myself looking back on what we have accomplished as a nation in pushing forward the comprehensive ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

Patrick Mahomes shares joyous Christmas photo in leg brace after ACL surgery Man Watched Moose For Years—Then Gets Doorbell ...

For some jurors, the hardest part of jury duty comes post-trial. A free West Chester University program helps those suffering ...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation to: ...

A drastic shift in plans for the BlueOval SK plant left many workers jobless. Here's what they said about the company's final ...

Gale Castillo will remain board chair through the end of December and attend board meetings in an advisory role for another three months, she said.